MiMedx Group Statistics
Share Statistics
MiMedx Group has 146.95M shares outstanding. The number of shares has increased by 26.44% in one year.
| Shares Outstanding | 146.95M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.54% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 115.49M |
| Failed to Deliver (FTD) Shares | 1.70K |
| FTD / Avg. Volume | 0.23% |
Short Selling Information
The latest short interest is 4.00M, so 2.72% of the outstanding shares have been sold short.
| Short Interest | 4.00M |
| Short % of Shares Out | 2.72% |
| Short % of Float | 3.49% |
| Short Ratio (days to cover) | 8.91 |
Valuation Ratios
The PE ratio is 15.15 and the forward PE ratio is 24.06.
| PE Ratio | 15.15 |
| Forward PE | 24.06 |
| PS Ratio | 3.18 |
| Forward PS | 3.5 |
| PB Ratio | 7.16 |
| P/FCF Ratio | 41.22 |
| PEG Ratio | n/a |
Enterprise Valuation
MiMedx Group Inc. has an Enterprise Value (EV) of 987.77M.
| EV / Earnings | 14.65 |
| EV / Sales | 3.07 |
| EV / EBITDA | 24.38 |
| EV / EBIT | 26.61 |
| EV / FCF | 39.85 |
Financial Position
The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.34.
| Current Ratio | 3.57 |
| Quick Ratio | 3.11 |
| Debt / Equity | 0.34 |
| Total Debt / Capitalization | 25.21 |
| Cash Flow / Debt | 0.56 |
| Interest Coverage | 5.75 |
Financial Efficiency
Return on equity (ROE) is 0.47% and return on capital (ROIC) is 42.82%.
| Return on Equity (ROE) | 0.47% |
| Return on Assets (ROA) | 0.28% |
| Return on Capital (ROIC) | 42.82% |
| Revenue Per Employee | 359.19K |
| Profits Per Employee | 75.35K |
| Employee Count | 895 |
| Asset Turnover | 1.34 |
| Inventory Turnover | 2.6 |
Taxes
| Income Tax | -36.81M |
| Effective Tax Rate | -1.2 |
Stock Price Statistics
The stock price has increased by 2.34% in the last 52 weeks. The beta is 1.94, so MiMedx Group 's price volatility has been higher than the market average.
| Beta | 1.94 |
| 52-Week Price Change | 2.34% |
| 50-Day Moving Average | 7.5 |
| 200-Day Moving Average | 7.11 |
| Relative Strength Index (RSI) | 64.9 |
| Average Volume (20 Days) | 753.48K |
Income Statement
In the last 12 months, MiMedx Group had revenue of $321.48M and earned $67.44M in profits. Earnings per share was $0.48.
| Revenue | 321.48M |
| Gross Profit | 266.84M |
| Operating Income | 37.12M |
| Net Income | 67.44M |
| EBITDA | 40.52M |
| EBIT | 37.12M |
| Earnings Per Share (EPS) | 0.48 |
Balance Sheet
The company has $82.00M in cash and $48.10M in debt, giving a net cash position of $33.90M.
| Cash & Cash Equivalents | 82.00M |
| Total Debt | 48.10M |
| Net Cash | 33.90M |
| Retained Earnings | -133.68M |
| Total Assets | 243.89M |
| Working Capital | 130.20M |
Cash Flow
In the last 12 months, operating cash flow was $26.77M and capital expenditures -$1.99M, giving a free cash flow of $24.79M.
| Operating Cash Flow | 26.77M |
| Capital Expenditures | -1.99M |
| Free Cash Flow | 24.79M |
| FCF Per Share | 0.21 |
Margins
Gross margin is 83.01%, with operating and profit margins of 11.55% and 20.98%.
| Gross Margin | 83.01% |
| Operating Margin | 11.55% |
| Pretax Margin | 9.53% |
| Profit Margin | 20.98% |
| EBITDA Margin | 12.6% |
| EBIT Margin | 11.55% |
| FCF Margin | 7.71% |
Dividends & Yields
MDXG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 5.23% |
| FCF Yield | 1.84% |
Analyst Forecast
The average price target for MDXG is $11.5, which is 25.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.5 |
| Price Target Difference | 25.4% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Stock Splits
The last stock split was on Apr 2, 2008. It was a backward split with a ratio of 647:2000.
| Last Split Date | Apr 2, 2008 |
| Split Type | backward |
| Split Ratio | 647:2000 |
Scores
| Altman Z-Score | 15.57 |
| Piotroski F-Score | 5 |